CHEK2 and non-small cell lung carcinoma: The levels of CYP24A1 (p < 0.001), CDC25C (p < 0.001), CHEK2 (p < 0.001), KLK6 (p = 0.044), S100P (p < 0.001), COL1A1 (p < 0.001), GPR37 (p < 0.001), and SLC7A5 (p < 0.001) mRNA expression were higher in cancerous tissues of patients with NSCLC than in corresponding controls (Figures 11A–H); whereas the levels of SCN1A (p < 0.001), CAV1 (p < 0.001), and GRIA1 (p < 0.001) mRNA expression in cancerous tissues of patients with NSCLC were lower than those in control tissues (Figures 11I–K).